Latest Benzimidazoles Stories
RIDGEFIELD, Conn., Oct. 19 /PRNewswire/ -- The U.S.
DEXILANT is the First Proton Pump Inhibitor (PPI) with a DUAL DELAYED RELEASE (DDR) Technology MISSISSAUGA, ON, Sept.
RIDGEFIELD, Conn., Aug. 29 /PRNewswire/ -- Boehringer Ingelheim today announced results from a pre-specified, retrospective, un-blinded sub-analysis of the RE-LYÂ® trial - the largest atrial fibrillation outcomes trial ever conducted(2) - were published in The Lancet.
PARIS, July 27 /PRNewswire-FirstCall/ -- Medco Research Institute(TM), LLC, a wholly owned subsidiary of Medco Health Solutions, Inc.
CINCINNATI, July 1 /PRNewswire/ -- Prasco Laboratories announced today that it is now shipping the authorized generic version of ZEGERIDÂ® (omeprazole/sodium bicarbonate) capsules.
Labeling changes will include new safety information SILVER SPRING, Md., May 25 /PRNewswire-USNewswire/ -- The U.S.
The results of several studies released on Monday are suggesting that certain heartburn medicines may be doing more harm than good.
NEW ORLEANS, May 5 /PRNewswire/ -- What: Data results from a recent retrospective analysis of DEXILANT delayed release capsules and lansoprazole were presented at Digestive Disease Week (DDW) 2010 in New Orleans.
DEERFIELD, Ill., April 26 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. today announced that DEXILANT(TM) (dexlansoprazole) delayed release capsules are now available in United States (U.S.) pharmacies.
- Having a loud voice; vociferous; clamorous.
- Of grand or imposing sound.